Abstract: Systems and methods are illustrated that relate to a web application running on a server accessible from the Internet. Aspects of the disclosure relate to the dynamic update of web applications/pages on third-party websites using an AJAX framework. The system may use properties files, business logic, and mapping table to facilitate cross-domain communication of the widget and the web application.

Abstract: Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. Also, the devices may be modified to promote endothelialization. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices.

Abstract: Provided is a torque tube assembly comprising a hollow composite member and an end fitting. The composite member has at least one end portion divided into a forward section and an aft section. The forward section is disposed adjacent a free end of the composite member. Each one of the forward and aft sections has at least one lobe extending radially outwardly along a lobe axis. The lobe axis of the forward section is preferably angularly offset from the lobe axis of the aft section. The end fitting is formed complementary to the composite member and is at least partially enclosed by the forward and aft sections.

Abstract: Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.

Abstract: 3,5-di-alkyl-4-hydroxybenzyl-substituted aromatics are made in improved yield by co-feeding 2,6-di-alkyl-4-alkoxymethyl phenol and sulfuric acid to a benzene compound, e.g. mesitylene, in an inert solvent at -10.degree. to 50.degree. C.